HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N(delta)- (N- methyl- N- nitrosocarbamoyl)- L- ornithine (MNCO)

Also Known As:
MNCO; MNC-ornithine; N-(N-methyl-N-nitroso-carbamyl)-L-ornithine; L-Ornithine, N(5)-((methylnitrosoamino)carbonyl)-
Networked: 16 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Li, Yang: 2 articles (01/2021 - 01/2021)
2. Liu, Zeming: 2 articles (01/2021 - 01/2021)
3. Fan, Quli: 1 article (01/2022)
4. Huang, Wei: 1 article (01/2022)
5. Jiang, Xinyue: 1 article (01/2022)
6. Li, Jiewei: 1 article (01/2022)
7. Sun, Bo: 1 article (01/2022)
8. Sun, Pengfei: 1 article (01/2022)
9. Wang, Hong: 1 article (01/2022)
10. Cai, Xiaojun: 1 article (01/2021)

Related Diseases

1. Neoplasms (Cancer)
2. Acinar Cell Carcinoma
3. Pancreatic Neoplasms (Pancreatic Cancer)
4. Carcinoma (Carcinomatosis)
5. Skin Neoplasms (Skin Cancer)

Related Drugs and Biologics

1. Manganese
2. N(delta)- (N- methyl- N- nitrosocarbamoyl)- L- ornithine (MNCO)
3. Therapeutic Uses
4. Biomarkers (Surrogate Marker)
5. Prodrugs
6. Indicators and Reagents (Reagents)
7. Glucose Oxidase
8. Glucose (Dextrose)
9. Buffers
10. Azaserine

Related Therapies and Procedures

1. Therapeutics
2. Precision Medicine
3. Microspheres (Microsphere)
4. Lasers (Laser)
5. Electrodes (Electrode)